Sp411
VACCINES FOR GI CANCERS: WE ARE (ALMOST) THERE
Date
May 19, 2024
Presenter
University of Kansas Medical Center/VAMC
Tracks
Related Products
YIELD OF MULTIGENE PANEL GERMLINE GENETIC TESTING AMONG THOSE WITH ADVANCED COLORECTAL ADENOMAS
BACKGROUND & AIM: Advanced adenomas (AAs) [≥1cm, villous, or high-grade dysplasia (HGD)] are precursors to colorectal cancer (CRC) and although guidelines support multi-gene panel testing (MGPT) in those with CRC, it is unclear if MGPT should be performed in individuals with CRC precursors…
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
